Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J.L. Heerspink, David C. Wheeler, Tom Greene et al.|New England Journal of Medicine|2020Cited by 5.2k
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J.L. Heerspink, Rey Isidto, Bergur V. Stefánsson et al.|Nephrology Dialysis Transplantation|2019Cited by 216